Literature DB >> 12915678

Transcription regulation of the multiple endocrine neoplasia type 1 gene in human and mouse.

Barbara Zablewska1, Lovisa Bylund, Slavena A Mandic, Maud Fromaget, Patrick Gaudray, Günther Weber.   

Abstract

Multiple endocrine neoplasia type I (MEN1) is an autosomal dominant tumor syndrome, with the presence of tumors in parathyroid, pancreatic, and anterior pituitary. The tumor suppressor gene MEN1, located on chromosome 11q13, encodes a 610 amino acid, 68-kDa protein, menin. Menin is conserved among species but has no similarity with any known protein. To investigate how the expression is regulated in both man and mouse, we assayed a greater than 1-kb region upstream of the second exon for promoter activity in luciferase reporter vectors. The basic promoter was located closely upstream the most commonly expressed first exon. The region further upstream modified the activity. Repetitive elements of the short interspersed/Alu type covered the entire human upstream regulatory region and were the only apparent motif in common with its murine ortholog. Previous studies have indicated a compensatory induction of the second allele because of inactivation of the first allele. We found that overexpression of menin in an inducible cell culture system down-regulated the proximal promoter. In response to down-regulation of MEN1 expression by RNA interference, the regulatory region activated the promoter in a compensatory manner. Our data confirm that the expression of the MEN1 gene is regulated by a feedback from its product menin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915678     DOI: 10.1210/jc.2003-030288

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  2 in total

1.  Somatostatin stimulates menin gene expression by inhibiting protein kinase A.

Authors:  Edith Mensah-Osman; Yana Zavros; Juanita L Merchant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-08-28       Impact factor: 4.052

Review 2.  Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

Authors:  Rajesh V Thakker
Journal:  Mol Cell Endocrinol       Date:  2013-08-08       Impact factor: 4.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.